科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/08/17 | 4,965 | 5,020 | 4,965 | 4,995 | ±0 | ±0% | 61,800 |
| 2021/08/16 | 5,020 | 5,030 | 4,960 | 4,995 | -25 | -0.5% | 68,200 |
| 2021/08/13 | 4,975 | 5,040 | 4,970 | 5,020 | +80 | +1.6% | 103,700 |
| 2021/08/12 | 4,960 | 4,980 | 4,925 | 4,940 | -10 | -0.2% | 68,300 |
| 2021/08/11 | 4,925 | 4,960 | 4,905 | 4,950 | +15 | +0.3% | 77,900 |
| 2021/08/10 | 4,880 | 4,950 | 4,875 | 4,935 | +50 | +1% | 72,900 |
| 2021/08/06 | 4,870 | 4,900 | 4,850 | 4,885 | +15 | +0.3% | 54,600 |
| 2021/08/05 | 4,850 | 4,935 | 4,850 | 4,870 | -15 | -0.3% | 72,400 |
| 2021/08/04 | 4,885 | 4,950 | 4,870 | 4,885 | ±0 | ±0% | 99,000 |
| 2021/08/03 | 4,925 | 4,955 | 4,845 | 4,885 | -85 | -1.7% | 134,400 |
| 2021/08/02 | 4,900 | 4,970 | 4,895 | 4,970 | +135 | +2.8% | 118,300 |
| 2021/07/30 | 4,850 | 4,870 | 4,825 | 4,835 | +10 | +0.2% | 222,700 |
| 2021/07/29 | 4,880 | 4,895 | 4,815 | 4,825 | -80 | -1.6% | 78,700 |
| 2021/07/28 | 4,865 | 4,920 | 4,855 | 4,905 | -10 | -0.2% | 70,500 |
| 2021/07/27 | 4,930 | 4,935 | 4,895 | 4,915 | +20 | +0.4% | 83,400 |
| 2021/07/26 | 4,930 | 4,940 | 4,855 | 4,895 | +45 | +0.9% | 89,100 |
| 2021/07/21 | 4,845 | 4,875 | 4,815 | 4,850 | +15 | +0.3% | 92,100 |
| 2021/07/20 | 4,780 | 4,860 | 4,775 | 4,835 | +10 | +0.2% | 89,700 |
| 2021/07/19 | 4,785 | 4,845 | 4,780 | 4,825 | +10 | +0.2% | 85,100 |
| 2021/07/16 | 4,805 | 4,880 | 4,805 | 4,815 | -45 | -0.9% | 81,000 |
| 2021/07/15 | 4,895 | 4,960 | 4,840 | 4,860 | -10 | -0.2% | 118,900 |
| 2021/07/14 | 4,795 | 4,895 | 4,795 | 4,870 | +70 | +1.5% | 93,900 |
| 2021/07/13 | 4,815 | 4,830 | 4,800 | 4,800 | +5 | +0.1% | 76,400 |
| 2021/07/12 | 4,790 | 4,815 | 4,765 | 4,795 | +100 | +2.1% | 99,500 |
| 2021/07/09 | 4,640 | 4,715 | 4,630 | 4,695 | -15 | -0.3% | 125,500 |
| 2021/07/08 | 4,775 | 4,775 | 4,710 | 4,710 | -85 | -1.8% | 107,800 |
| 2021/07/07 | 4,760 | 4,795 | 4,725 | 4,795 | -25 | -0.5% | 104,500 |
| 2021/07/06 | 4,825 | 4,835 | 4,805 | 4,820 | +5 | +0.1% | 62,000 |
| 2021/07/05 | 4,860 | 4,895 | 4,815 | 4,815 | -45 | -0.9% | 96,000 |
| 2021/07/02 | 4,885 | 5,010 | 4,860 | 4,860 | +75 | +1.6% | 317,600 |
| 2021/07/01 | 4,760 | 4,815 | 4,750 | 4,785 | +25 | +0.5% | 97,900 |
| 2021/06/30 | 4,790 | 4,795 | 4,755 | 4,760 | -30 | -0.6% | 89,400 |
| 2021/06/29 | 4,790 | 4,815 | 4,765 | 4,790 | -45 | -0.9% | 79,800 |
| 2021/06/28 | 4,850 | 4,870 | 4,810 | 4,835 | +10 | +0.2% | 104,100 |
| 2021/06/25 | 4,840 | 4,850 | 4,790 | 4,825 | -5 | -0.1% | 91,800 |
| 2021/06/24 | 4,765 | 4,840 | 4,760 | 4,830 | +65 | +1.4% | 120,400 |
| 2021/06/23 | 4,755 | 4,810 | 4,755 | 4,765 | +5 | +0.1% | 115,700 |
| 2021/06/22 | 4,735 | 4,760 | 4,680 | 4,760 | +140 | +3% | 143,500 |
| 2021/06/21 | 4,650 | 4,665 | 4,605 | 4,620 | -120 | -2.5% | 129,700 |
| 2021/06/18 | 4,795 | 4,795 | 4,730 | 4,740 | -55 | -1.1% | 142,500 |
| 2021/06/17 | 4,770 | 4,810 | 4,765 | 4,795 | +40 | +0.8% | 108,500 |
| 2021/06/16 | 4,700 | 4,790 | 4,700 | 4,755 | ±0 | ±0% | 132,600 |
| 2021/06/15 | 4,820 | 4,835 | 4,755 | 4,755 | -65 | -1.3% | 114,800 |
| 2021/06/14 | 4,820 | 4,845 | 4,785 | 4,820 | +5 | +0.1% | 110,800 |
| 2021/06/11 | 4,795 | 4,815 | 4,765 | 4,815 | +50 | +1% | 139,200 |
| 2021/06/10 | 4,795 | 4,800 | 4,730 | 4,765 | +40 | +0.8% | 124,200 |
| 2021/06/09 | 4,710 | 4,795 | 4,710 | 4,725 | -10 | -0.2% | 120,700 |
| 2021/06/08 | 4,710 | 4,750 | 4,710 | 4,735 | +40 | +0.9% | 96,800 |
| 2021/06/07 | 4,650 | 4,710 | 4,650 | 4,695 | +45 | +1% | 119,300 |
| 2021/06/04 | 4,650 | 4,665 | 4,640 | 4,650 | +25 | +0.5% | 104,500 |
901～
950
件表示中 / 3684件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 413,700円 | +30.5% | +111.0% | 4.59% | 11.66倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 住友ファーマ | 62,700円 | +21.1% | - | 0.00% | 15.57倍 | 2.18倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ペプチド | 187,600円 | +5.0% | +1.5% | 0.00% | 16.10倍 | 4.28倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 381,500円 | +14.5% | -2.3% | 2.36% | 13.96倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 226,700円 | - | - | 0.00% | - | 105.00倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
